Recruiting nowEarly Phase 1
Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity
Updated 2026-08-18 · NCT07065591See eligibility →
Sponsor
Clinical trials sponsored by The University of Hong Kong
Active studies whose public registry record names The University of Hong Kong as lead sponsor.
8active studies
4recruiting now
1countries represented
3largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-02-02 · NCT07379970See eligibility →
Recruiting nowPhase 3
Effect of Semaglutide in Patients With Psoriasis and Obesity
Updated 2025-05-13 · NCT06937060See eligibility →
Recruiting nowNot applicable
Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLD
Updated 2024-07-09 · NCT06124456See eligibility →
Opening soonNot applicable
E-Health Lifestyle Intervention for Arthritis: A Pilot RCT on Feasibility
Updated 2026-08-25 · NCT07786038See eligibility →
Updated 2025-06-11 · NCT06996431See eligibility →
Active, not recruitingEarly Phase 1
Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist
Updated 2026-08-19 · NCT06807970See eligibility →
Active, not recruitingNot applicable
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
Updated 2026-05-01 · NCT05741957See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.